Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H36O7 |
Molecular Weight | 424.5277 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC
InChI
InChIKey=TUZYXOIXSAXUGO-PZAWKZKUSA-N
InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1
Molecular Formula | C23H36O7 |
Molecular Weight | 424.5277 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:54:46 UTC 2023
by
admin
on
Sat Dec 16 16:54:46 UTC 2023
|
Record UNII |
KXO2KT9N0G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QC10BX02
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
NDF-RT |
N0000175589
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
WHO-VATC |
QC10BA03
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
WHO-VATC |
QC10AA03
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
WHO-ATC |
C10BA03
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
LIVERTOX |
NBK548653
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
WHO-ATC |
C10BX02
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
WHO-ATC |
C10AA03
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
NDF-RT |
N0000000121
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
NCI_THESAURUS |
C1655
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/10/748
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2239
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
54687
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
KXO2KT9N0G
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
81093-37-0
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
2953
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
DB00175
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
PRAVASTATIN
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
D017035
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
100000091161
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
SUB10004MIG
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
DTXSID6023498
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
6070
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL1144
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
KXO2KT9N0G
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
Pravastatin
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
63660
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
42463
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
C62070
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
63618
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY | |||
|
8368
Created by
admin on Sat Dec 16 16:54:48 UTC 2023 , Edited by admin on Sat Dec 16 16:54:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
PARENT -> METABOLITE LESS ACTIVE |
MAJOR
|
||
|
PARENT -> METABOLITE INACTIVE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
PROTEIN BINDING | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Route of Elimination | PHARMACOKINETIC |
|
RENAL PHARMACOKINETIC |
|
||
Tmax | PHARMACOKINETIC |
|
|
|||